International Clinical Trial: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06979336) titled 'A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)' on May 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Genentech, Inc.

Condition: Ulcerative Colitis

Intervention: Drug: RO7837195

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: May 26, 2025

Target Sample Size: 224

To know more, visit ...